INDIVIOR PHARMACEUTICALS INC (INDV) competitors & alternatives
Health Care · NASDAQ
INDIVIOR PHARMACEUTICALS INC (INDV)'s top competitors and alternatives — its most similar public companies — include COLLEGIUM PHARMACEUTICAL INC (COLL), Jazz Pharmaceuticals (JAZZ), ADMA BIOLOGICS INC (ADMA), ETON PHARMACEUTCIALS INC (ETON), AQUESTIVE THERAPEUTICS INC (AQST), ALKERMES (ALKS), Acadia Healthcare (ACHC), ATAIBECKLEY INC (ATAI), DEFINIUM THERAPEUTICS INC (DFTX), HERON THERAPEUTICS INC (HRTX), ANI PHARMACEUTICALS INC (ANIP) and Cencora (COR). These are INDIVIOR PHARMACEUTICALS INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top INDV competitors & alternatives
-
COLLEGIUM PHARMACEUTICAL INCCOLLHealth Care
A specialty pharma company building a diversified pain and ADHD portfolio through branded products and acquisitions, though facing material generic headwinds…
$34.72 (as of 2026-07-22) · market cap $1.1B
-
Jazz PharmaceuticalsJAZZHealth Care
A rare-disease biopharmaceutical company with diversified marketed therapies in epilepsy, sleep disorders, and oncology, and an expanding pipeline of…
$250.41 (as of 2026-07-22) · market cap $16.0B
-
ADMA BIOLOGICS INCADMAHealth Care
ADMA manufactures and markets FDA-approved plasma-derived immune globulin products for immunodeficient and infectious disease patients, operating an integrated…
$8.38 (as of 2026-07-22) · market cap $2.0B
-
ETON PHARMACEUTCIALS INCETONHealth Care
Eton Pharmaceuticals develops and commercializes rare disease treatments, with a portfolio of ten marketed products and four late-stage candidates targeting…
$43.58 (as of 2026-07-22) · market cap $1.2B
-
AQUESTIVE THERAPEUTICS INCAQSTHealth Care
Aquestive develops orally disintegrating film formulations for CNS disorders, acute seizures, and opioid use, leveraging proprietary sublingual and buccal film…
$3.94 (as of 2026-07-22) · market cap $496M
-
ALKERMESALKSHealth Care
Alkermes is a neuroscience-focused biopharmaceutical company commercializing branded therapies for schizophrenia, bipolar disorder, narcolepsy, and substance…
$52.58 (as of 2026-07-22) · market cap $8.8B
-
Acadia HealthcareACHCHealth Care
A leading operator of residential, acute-care, and outpatient behavioral health facilities serving patients with serious mental illness, addiction, and other…
$34.78 (as of 2026-07-22) · market cap $3.3B
-
ATAIBECKLEY INCATAIHealth Care
A clinical-stage biotechnology company dedicated to developing innovative mental health therapies through a diverse pipeline of neuropsychiatric treatments.
$7.18 (as of 2026-07-22) · market cap $2.7B
-
DEFINIUM THERAPEUTICS INCDFTXHealth Care
Definium is applying scientific rigor to psychedelics and empathogens to develop FDA-breakthrough-designated treatments for anxiety, depression, PTSD, and…
$43.67 (as of 2026-07-22) · market cap $5.8B
-
HERON THERAPEUTICS INCHRTXHealth Care
A commercial-stage biotech company bringing specialized injectable medicines to acute care and oncology settings, with a focus on non-opioid pain management…
$0.47 (as of 2026-07-22) · market cap $90M
-
ANI PHARMACEUTICALS INCANIPHealth Care
A diversified biopharmaceutical company focused on growing its Rare Disease, Brands, and Generics segments through a combination of internal development and…
$77.61 (as of 2026-07-22) · market cap $1.8B
-
CencoraCORHealth Care
North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs,…
$300.58 (as of 2026-07-22) · market cap $58.5B
Not quite? Describe exactly what you want →
Peers are INDIVIOR PHARMACEUTICALS INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: INDIVIOR PHARMACEUTICALS INC (INDV).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.